There were 694 press releases posted in the last 24 hours and 150,807 in the last 365 days.

Teligent, Inc. to Present at the J.P. Morgan 36th Annual Healthcare Conference January 10th

BUENA, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the J.P. Morgan 36th Annual Healthcare Conference. The Conference is taking place January 8-11, 2018 at the Westin St. Francis Hotel, San Francisco, CA.

Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will present on Wednesday, January 10, 2018 at 11:00 a.m. PT. 

The presentation will be webcast and will be accessible online on the investors section of the Company's website at  A replay will be available for 30 days.  

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website

Jenniffer Collins
Teligent, Inc.
(856) 697-4379     

/EIN News/ --

Primary Logo

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.